These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 22967767)
1. Allylic thiocyanates as a new class of antitubercular agents. Silveira GP; Ferreira M; Fernandes L; Moraski GC; Cho S; Hwang C; Franzblau SG; Sá MM Bioorg Med Chem Lett; 2012 Oct; 22(20):6486-9. PubMed ID: 22967767 [TBL] [Abstract][Full Text] [Related]
2. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis. Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240 [TBL] [Abstract][Full Text] [Related]
3. Novel dihydropyrimidines as a potential new class of antitubercular agents. Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528 [TBL] [Abstract][Full Text] [Related]
4. Structural requirements for the antitubercular quaternized triflupromazine pharmacophore. Kunciw DL; Liechty JJ; Mitchell MO; Wan B; Franzblau SG Bioorg Med Chem Lett; 2012 Sep; 22(17):5679-80. PubMed ID: 22850215 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749 [TBL] [Abstract][Full Text] [Related]
9. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents. Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents. Bacelar AH; Carvalho MA; Proença MF Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380 [TBL] [Abstract][Full Text] [Related]
12. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Braendvang M; Bakken V; Gundersen LL Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890 [TBL] [Abstract][Full Text] [Related]
14. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development. Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577 [TBL] [Abstract][Full Text] [Related]
15. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis. Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives. Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492 [TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). Gordien AY; Gray AI; Franzblau SG; Seidel V J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1. Lu X; Wan B; Franzblau SG; You Q Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies. Chitra S; Paul N; Muthusubramanian S; Manisankar P; Yogeeswari P; Sriram D Eur J Med Chem; 2011 Oct; 46(10):4897-903. PubMed ID: 21855182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]